-
Sinovation Secures Over RMB 100 Million in Series D+ Financing for Neurosurgery Innovations
•
Beijing-based Sinovation (Beijing) Medical Technology Co., Ltd., a leader in neurosurgery diagnosis, minimally invasive procedure treatment, and smart industry platform, has reportedly raised over RMB 100 million (USD 14 million) in a Series D+ financing round. The round saw participation from notable investors such as Xinda Kunpeng Investment, Tsing Ventures,…
-
Sinovation Medical’s SinoLITT System and Fiber Kit Gain NMPA Approval for Epilepsy Treatment
•
Sinovation (Beijing) Medical Technology Co., Ltd has announced that its in-house developed magnetic resonance monitoring semiconductor laser therapy equipment, the SinoLITT System, and disposable laser fiber kit have been approved by the National Medical Products Administration (NMPA) for use in laser treatment of local lesions in patients with drug-resistant epilepsy,…
